Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Sequencing System Increases Data Production While Reducing Costs.

By LabMedica International staff writers
Posted on 27 Jan 2010
Researchers engaged in human genome sequencing and profiling will benefit from the introduction of a new, low cost, high output system.

The new instrument, the Illumina Inc. More...
(San Diego, CA, USA) HiSeq 2000, is capable of generating two billion paired-end reads and 200 gigabases (Gb) of quality filtered data in a single run. The system uses two flow cells and an innovative dual-surface imaging method, enabling new levels of sequencing output as well as experimental flexibility.

For the operator the HiSeq 2000 offers streamlined and intuitive single operator workflow; initiating a run requires less than 10 minutes total hands-on time. Preconfigured plug-and-play reagents, a touch screen user interface, and real-time and remote run monitoring result in simpler instrument operation. Jay Flatley, president and CEO of Illumina, said, "These innovations redefine the trajectory of sequencing and, for the first time, take the cost of sequencing a human genome below $10,000."

"HiSeq will have a major impact on a broad range of applications, including advancing our understanding of cancer and other complex genetic diseases. We can now sequence two human genomes in a single run--for example, a tumor and a normal sample--at 30-fold coverage," said Dr. David Bentley, vice president and chief scientist at Illumina. "The unprecedented output and cost-effective operation will make human genome sequencing routine and allow researchers to easily compare entire genomes, transcriptomes, and epigenomes."

The HiSeq 2000 sequencing system began shipping in limited quantities to selected sites in February 2009, and is expected to ship broadly in March 2010.

Related Links:

Illumina Inc.



Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.